Biophotonics Market by End User and Application: Global Opportunity Analysis and Industry Forecast, 2014–2022, the global Biophotonics Market size is estimated to reach $63.1 billion by 2022 from $31.6 billion in 2015, growing at a CAGR of 10.4% from 2016 to 2022. In 2015, North America dominated with over 37% share of the overall market and is anticipated to continue this trend during the forecast period.
In 2015, medical diagnostics held over 68% market share, in terms of revenue. Technological advancements in the field of diagnostics, rise in incidences of chronic diseases, and increase in healthcare awareness are the key factors that contribute to the growth of the biophotonics market. Moreover, owing to increase in geriatric population, the role and importance of medical diagnostics are expanding, which considerably drives the market growth.
By application, the see-through imaging segment held over 28% of the revenue share in 2015, owing to increase in research in this field. North America dominated the global biophotonics market with over 36% share in overall revenue and is anticipated to grow at the CAGR of 9.5%, followed by Europe, Asia-Pacific, and LAMEA.
Emergence Of Nanotechnology Leads To The Development Of Biophotonics
Nanotechnology is a science that deals with dimensions at the nanoscale, which is about 1 to 100 nanometers. This technology is applicable across all the other science fields such as chemistry, biology, physics, materials science, and engineering.
The graph above shows the increase in market size of nanotechnology, and is expected to reach around $100,000 million, which fuels the market growth. Nanotechnology enhances the activity or sensing technology of biophotonics-based devices.
Practice of nano technology in healthcare sector helps a lot in sensing human cells and tissues. For example, for a cancer patient usage of biophotonics helps in connecting with the directly affected cells and improves the process of curing. The increase in penetration of advanced healthcare devices fuel the growth in biophotonics market
The emergence of nanotechnology, R&D in the field of optics, increased use of biophotonic devices for medical & nonmedical purposes, and high equipment cost have a significant impact on the growth of the market. Each of these factors is expected to have its definite impact on the market during the forecast period.
Biophotonics Market Key Findings
- Medical diagnostics segment dominated the market in 2015, with over 68% of market share. However, nonmedical application segment is expected to grow at a higher CAGR of 14.3%.
- See-through imaging application segment accounted for about 28% of the market in 2015.
- LAMEA is anticipated to show high growth rate owing to the rapidly growing automotive industry.
- Asia-Pacific dominated the market in 2015 due surge in demand for biophotonics-based devices in China, South Korea, and Japan.
The major players profiled in the report include Affymetrix Inc.; Andor Technology Ltd.; Carl Zeiss AG; Becton, Dickinson and Company; FEI Company; Hamamatsu Photonics K.K.; Lumenis Ltd.; Olympus Corporation; PerkinElmer Inc.; and Zecotek Photonics Inc.
The post Biophotonics Market Steady Expansion & Comprehensive Growth By 2022 appeared first on Articles For Website.
This post first appeared on Find Appropriate Analytics Projects Online And Help Your Analytics Talent To Grow, please read the originial post: here